4th Drug Formulation and Bioavailability 2015

Key Topics

• Selecting Methodologies, Priorities, and Risks in Salt and Polymorph Screening
• The Industry`s Technical and Regulatory Path Forward for Pediatric Formulations
• Avoid Underpredicting Exposures Through Better Modeling of Enabled Formulations
• Future Trends in Drug Formulation: Agnostic Modality
• Rethinking Early-Stage Formulation Methods
• Team Leadership Styles for Advanced Formulation Development
• Novel Automated Analysis Methods for Biorelevant Dissolution
• Utilization of Formulation Design Space to Accelerate Early Clinical Development of Drug Products

Who should Attend

Attendees with responsibilities in:

• Preclinical Development
• Pharmaceutical Development
• Preformulation
• Formulation
• Physicochemistry
• Medicinal/Analytical/Solid-State Chemistry
• Pharmacokinetics/DMPK
• Pharmaceutics/Biopharmaceutics
• Drug Discovery
• Drug Delivery
• Toxicology
• Material Science
• Chemical Engineering
• Lifecycle/Portfolio Management
• Process R&D